Atezolizumab-induced linear IgA bullous dermatosis

Br J Dermatol. 2022 Dec;187(6):e193. doi: 10.1111/bjd.21653. Epub 2022 Jun 7.

Authors

Silvia Aguilar-Duran¹, John Mee², Sanjay Popat^{1

3}, Kara Heelan¹

Affiliations

¹ Department of Dermatology, Royal Marsden Hospital NHS Trust, London, UK.
² Immunodermatology Laboratory, St Thomas' Hospital, London, UK.
³ Institute of Cancer Research, Division of Cancer Therapeutics, London, UK.

PMID: 35670360
DOI: 10.1111/bjd.21653

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Monoclonal, Humanized / adverse effects
Humans
Immunoglobulin A
Linear IgA Bullous Dermatosis* / chemically induced
Linear IgA Bullous Dermatosis* / diagnosis

Substances

atezolizumab
Antibodies, Monoclonal, Humanized
Immunoglobulin A